News-Medical speaks to Dr. Dan Lavery about the LouLou Foundation, a non-profit organization dedicated to CDLK5 Deficiency Disorder.
Guidelines and best practices to provide care for seniors during COVID-19 pandemic
China's control measures during the first 50 days may have limited spread of COVID-19
Wearable delivery device allows adults with type 2 diabetes to safely use affordable insulin therapy
Location of broken bone in older people can have major impact on long-term health outcomes
Three Australian experts explain the course of COVID-19
Hypothyroidism patients cite effectiveness of desiccated thyroid extract over standard therapy
What are Coronaviruses?
What is the Difference Between COVID-19 and the Flu?
Differences in the Brains of People with Severe Mental Illnesses
Dr Maureen Bunger
Lonza is a large, multinational corporation serving the entire pharmaceutical product development and manufacturing pipeline, from non-clinical research products to final dosage and delivery solutions.
Dr. Dan Lavery
Mark White, Ph.D.
Researchers are in desperate need of single-cell analysis techniques and those that allow the isolation of high-value T-cells for research and development.